BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35578189)

  • 1. Identification of miRNA biomarkers for stomach adenocarcinoma.
    Qian H; Cui N; Zhou Q; Zhang S
    BMC Bioinformatics; 2022 May; 23(1):181. PubMed ID: 35578189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
    Luo SS; Liao XW; Zhu XD
    J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcriptome sequencing and miRNA-mRNA network construction in exosome of macrophage M2 in stomach adenocarcinoma.
    Pan D; Li Z; Lin X; Li L
    World J Surg Oncol; 2023 Jun; 21(1):193. PubMed ID: 37370118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of expression profile of miRNA in stomach adenocarcinoma.
    Huo Q
    J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
    Liu J; Liu F; Shi Y; Tan H; Zhou L
    FEBS Open Bio; 2018 Feb; 8(2):279-294. PubMed ID: 29435418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.
    Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
    Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
    [No Abstract]   [Full Text] [Related]  

  • 12. Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression.
    Wu X; Wang Y; Chen C; Xue Y; Zheng S; Cai L
    Genet Res (Camb); 2022; 2022():5671562. PubMed ID: 35903462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
    Li T; Liu H; Dong C; Lyu J
    Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis.
    Ren ZJ; Zhao Y; Wang G; Miao LL; Zhang ZC; Ma L; Teng MZ; Li YM
    Clin Chim Acta; 2022 Jun; 531():25-35. PubMed ID: 35300960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
    Chang JT; Wang F; Chapin W; Huang RS
    PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; GuimarĂ£es ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
    Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
    Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H
    Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.